Semi-Annual Consolidated Statement Of Income

COSMOS Pharmaceutical Corporation - Filing #7569860

Concept 2022-06-01 to
2023-02-28
2021-06-01 to
2022-02-28
Semi-annual consolidated statement of income
Statement of income
Net sales
606,302,000,000 JPY
558,885,000,000 JPY
Cost of sales
481,993,000,000 JPY
447,432,000,000 JPY
Gross profit (loss)
124,309,000,000 JPY
111,453,000,000 JPY
Ordinary profit (loss)
24,393,000,000 JPY
24,100,000,000 JPY
Extraordinary income
39,000,000 JPY
499,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
102,142,000,000 JPY
89,555,000,000 JPY
Extraordinary losses
199,000,000 JPY
202,000,000 JPY
Operating profit (loss)
22,167,000,000 JPY
21,897,000,000 JPY
Profit (loss) before income taxes
24,232,000,000 JPY
24,397,000,000 JPY
Non-operating income
Interest income
35,000,000 JPY
38,000,000 JPY
Non-operating income
2,717,000,000 JPY
2,695,000,000 JPY
Non-operating expenses
Interest expenses
34,000,000 JPY
40,000,000 JPY
Non-operating expenses
491,000,000 JPY
493,000,000 JPY
Income taxes
7,948,000,000 JPY
7,942,000,000 JPY
Profit (loss)
16,283,000,000 JPY
16,455,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
265,000,000 JPY
Extraordinary losses
Loss on disaster
4,000,000 JPY
25,000,000 JPY
Profit (loss) attributable to owners of parent
16,283,000,000 JPY
16,455,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
0 JPY
0 JPY
Remeasurements of defined benefit plans, net of tax
7,000,000 JPY
11,000,000 JPY
Other comprehensive income
7,000,000 JPY
10,000,000 JPY
Comprehensive income
16,291,000,000 JPY
16,466,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
16,291,000,000 JPY
16,466,000,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.